Zomedica Announces Record Third Quarter 2023 Financial Resul

Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion

Related Keywords

United States , Ann Arbor , Michigan , American , Larry Heaton , Qorvo Biotechnologies , Exchange Commission On , Pathology Department , Monitoring Products Inc , Zomedica Corp , Quarter Financial , Therapeutic Devices , Structured Monitoring , Structured Monitoring Products , Current Report , Exchange Commission , Company Guide , Quarter Results , Chief Financial Officer , Revo Squared , Outstanding Share , Call Details , Results Conference , Relations Contact , Three Months , Region ,